These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12880701)

  • 1. Structure formation in injectable poly(lactide-co-glycolide) depots.
    Wang L; Kleiner L; Venkatraman S
    J Control Release; 2003 Jul; 90(3):345-54. PubMed ID: 12880701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug release from injectable depots: two different in vitro mechanisms.
    Wang L; Venkatraman S; Kleiner L
    J Control Release; 2004 Sep; 99(2):207-16. PubMed ID: 15380631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure formation in injectable poly(lactide-co-glycolide) depots. II. Nature of the gel.
    Wang L; Venkatraman S; Gan LH; Kleiner L
    J Biomed Mater Res B Appl Biomater; 2005 Jan; 72(1):215-22. PubMed ID: 15514938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
    Desai KG; Mallery SR; Schwendeman SP
    Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetracycline-HCl-loaded poly(DL-lactide-co-glycolide) microspheres prepared by a spray drying technique: influence of gamma-irradiation on radical formation and polymer degradation.
    Bittner B; Mäder K; Kroll C; Borchert HH; Kissel T
    J Control Release; 1999 May; 59(1):23-32. PubMed ID: 10210719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein instability in poly(lactic-co-glycolic acid) microparticles.
    van de Weert M; Hennink WE; Jiskoot W
    Pharm Res; 2000 Oct; 17(10):1159-67. PubMed ID: 11145219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained release microspheres of metoclopramide using poly(D,L-lactide-co-glycolide) copolymers.
    Elkheshen SA; Radwan MA
    J Microencapsul; 2000; 17(4):425-35. PubMed ID: 10898083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicomechanical properties of biodegradable poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) films in the dry and wet states.
    Kranz H; Ubrich N; Maincent P; Bodmeier R
    J Pharm Sci; 2000 Dec; 89(12):1558-66. PubMed ID: 11042603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injectable in situ forming depot systems: PEG-DAE as novel solvent for improved PLGA storage stability.
    Schoenhammer K; Petersen H; Guethlein F; Goepferich A
    Int J Pharm; 2009 Apr; 371(1-2):33-9. PubMed ID: 19135512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase inversion dynamics of PLGA solutions related to drug delivery. Part II. The role of solution thermodynamics and bath-side mass transfer.
    Brodbeck KJ; DesNoyer JR; McHugh AJ
    J Control Release; 1999 Dec; 62(3):333-44. PubMed ID: 10528071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and release characteristics.
    Walter E; Moelling K; Pavlovic J; Merkle HP
    J Control Release; 1999 Sep; 61(3):361-74. PubMed ID: 10477808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro release of levonorgestrel from phase sensitive and thermosensitive smart polymer delivery systems.
    Chen S; Singh J
    Pharm Dev Technol; 2005; 10(2):319-25. PubMed ID: 15926681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF.
    Pettit DK; Lawter JR; Huang WJ; Pankey SC; Nightlinger NS; Lynch DH; Schuh JA; Morrissey PJ; Gombotz WR
    Pharm Res; 1997 Oct; 14(10):1422-30. PubMed ID: 9358556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of ciclosporin A loaded poly (D,L lactide-co-glycolide) microspheres using modulated temperature differential scanning calorimetry.
    Passerini N; Craig DQ
    J Pharm Pharmacol; 2002 Jul; 54(7):913-9. PubMed ID: 12162709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C; Doelker E
    J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist.
    Du L; Cheng J; Chi Q; Qie J; Liu Y; Mei X
    Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1259-65. PubMed ID: 16946531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.
    Li Y; Pei Y; Zhang X; Gu Z; Zhou Z; Yuan W; Zhou J; Zhu J; Gao X
    J Control Release; 2001 Apr; 71(2):203-11. PubMed ID: 11274752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled delivery of drugs from a novel injectable in situ formed biodegradable PLGA microsphere system.
    Jain RA; Rhodes CT; Railkar AM; Malick AW; Shah NH
    J Microencapsul; 2000; 17(3):343-62. PubMed ID: 10819422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled delivery of therapeutics from microporous membranes. II. In vitro degradation and release of heparin-loaded poly(D,L-lactide-co-glycolide).
    Kreitz MR; Domm JA; Mathiowitz E
    Biomaterials; 1997 Dec; 18(24):1645-51. PubMed ID: 9613812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of additives on the release profile of nifedipine from poly(DL-lactide-co-glycolide) microspheres.
    Sansdrap P; Moës AJ
    J Microencapsul; 1998; 15(5):545-53. PubMed ID: 9743911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.